Yeast Platforms for Production and Screening of Bioactive Derivatives of Rauwolscine
Samuel A. Bradley,Frederik G. Hansson,Beata J. Lehka,Daniela Rago,Pedro Pinho,Huadong Peng,Khem B. Adhikari,Ahmad K. Haidar,Lea G. Hansen,Daria Volkova,Maxence Holtz,Sergi Muyo Abad,Xin Ma,Konstantinos Koudounas,Sébastien Besseau,Nicolas Gautron,Céline Mélin,Jillian Marc,Caroline Birer Williams,Vincent Courdavault,Emil D. Jensen,Jay D. Keasling,Jie Zhang,Michael K. Jensen
DOI: https://doi.org/10.1021/acssynbio.4c00039
IF: 5.249
2024-04-19
ACS Synthetic Biology
Abstract:Monoterpene indole alkaloids (MIAs) make up a highly bioactive class of metabolites produced by a range of tropical and subtropical plants. The corynanthe-type MIAs are a stereochemically complex subclass with therapeutic potential against a large number of indications including cancer, psychotic disorders, and erectile dysfunction. Here, we report yeast-based cell factories capable of de novo production of corynanthe-type MIAs rauwolscine, yohimbine, tetrahydroalstonine, and corynanthine. From...
biochemical research methods